AP00047CP-N Caspase-7 Control Peptide

Search for all "Caspase-7"

50 µg / 180,00 €
Please visit the country specific website of OriGene Technologies or contact your local Distributor to buy this product.

Kurzübersicht

anti Caspase-7

AP00047CP-N

Produktbeschreibung für Caspase-7

anti Caspase-7.
Properties: Control Peptide
Presentation: Purified

Produktdaten von Caspase-7

Produkt-Kategorie Control Peptides
Target-Kategorie
Menge 50 µg
Synonyme Apoptotic protease Mch-3, CASP-7, CASP7, CMH-1, ICE-like apoptotic protease 3, MCH3
Präsentation Purified
Klonalität Polyclonal
Shipping to Worldwide
PDF datasheet Datenblatt ansehen
Hersteller OriGene Technologies GmbH
Material safety datasheet MSDS for Polyclonal Antibodies (de)

Datenblatt-Auszug

Immunogen
Swiss Prot Num:
P55210
GeneID:
840
Anwendung Western blot: It usually blocks the antibody activity completely in Western blot analysis by incubating the peptide with equal volume of antibody for 30 minutes at 37 °C.
Background Caspases are cysteine proteases, expressed as inactive precursors, that mediate apoptosis by proteolysis of specific substrates. Caspases have the ability to cleave after aspartic acid residues. There are two classes of caspases involved in apoptosis; initiators (activation by receptor cluster) and effectors (activation by mitochondrial permeability transition). Proapoptotic signals autocatalytically activate initiator caspases, such as Caspase 8 and Caspase 9. Activated initiator caspases then process effector caspases, such as Caspase 3 and Caspase 7, which in turn cause cell collapse.
Concentration 0.2 mg/ml
Storage Store the antibody undiluted at -20°C or for long term storage (in aliquots) at -70°C.
Avoid repeated freezing and thawing.
Shelf life: one year from despatch.
Format
Buffer System:
PBS, pH 7.2, containing 0.1% BSA and .02% thimerosal
Purity:
purified
State:
Liquid peptide
Purified
Specificity
Specificity:
Control peptide for antibody AP00047PU-N only.
Gene ID 840
FocusOn and Reviews
FocusOns:

Accessory Products

  • LinkedIn